Dr. Raymond John Orgler, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 547 E. Main St, Louisville, MS 39339 Phone: 662-773-8574 Fax: 662-773-7934 |
News Archive
Staff at the University of Liverpool's Department of Eye & Vision Science have been awarded £1.3 million by the National Institute for Health Research's Intervention for Innovation (i4i) program to develop a state-of-the-art Ultra-Sensitive Optical Coherence Tomography system.
In this Center for Global Development Global Health Policy blog post, Amanda Glassman, director of Global Health Policy and research fellow at CGD, and Denizhan Duran, a CGD research assistant, examine the question of whether European and other aid agencies should continue to give aid to India, a country that "now plans to give $11.3 billion in the next five to seven years" through its own aid agency.
Researchers from the Lille Centre for Infection and Immunity, INRAE and from Brazilian (Belo Horizonte), Scottish (Glasgow) and Danish (Copenhagen) laboratories have shown for the first time in mice that perturbation of the gut microbiota caused by the influenza virus favors secondary bacterial superinfection.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration has issued 510(k) clearance to the Simplexa Influenza A H1N1 (2009) test on the 3M Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is the first to be cleared by the FDA for use as an aid in the detection and differentiation of influenza A and 2009 H1N1 influenza viral RNA.
Emisphere Technologies, Inc. today announced that on August 25, 2010, Emisphere Technologies, Inc. entered into a securities purchase agreement with certain institutional investors pursuant to which the Company has agreed to sell an aggregate of 3,497,528 shares of its common stock and warrants to purchase a total of 2,623,146 additional shares of its common stock for total gross proceeds of $3,532,503.28.
› Verified 4 days ago